MetaGenomika
MetaGenomika provides AI-powered molecular diagnostics to improve detection and management of chronic diseases. It uses AI to interpret genomic and molecular data from patient samples to identify disease signals. The company operates as a biotechnology firm offering diagnostic products for clinics and laboratories, focusing on AI-powered molecular assays. Core technologies include AI and machine learning, genomics data, and molecular diagnostic assays. The market strategy centers on partnerships with healthcare providers to enable personalized medicine at scale.
MetaGenomika
MetaGenomika provides AI-powered molecular diagnostics to improve detection and management of chronic diseases. It uses AI to interpret genomic and molecular data from patient samples to identify disease signals. The company operates as a biotechnology firm offering diagnostic products for clinics and laboratories, focusing on AI-powered molecular assays. Core technologies include AI and machine learning, genomics data, and molecular diagnostic assays. The market strategy centers on partnerships with healthcare providers to enable personalized medicine at scale.